Legal Cbd Oils Have Been Used To Treat The Condition For Years, And Epidolex, A Pipeline Drug From Gw Pharmaceuticals (nasdaq: Gwph ) Has Had Strong Clinical Results.

On top of this, MJNA’s portfolio company, Axim Biotechnologies ( OTCQB:AXIM ), is listed on the OTC markets and has questionable transparency and weird expenditures. Many of MJNA’s holdings are illiquid, and it may be difficult for MJNA to realize full market value if it ever decided to sell its equity stakes in its portfolio companies. Cannabidiol in the Treatment of Epilepsy Currently, there is little doubt that CBD is an effective treatment Green Rush for epilepsy indications. Legal CBD oils have been used to treat the condition for years, and Epidolex, a pipeline drug from GW Pharmaceuticals (NASDAQ: GWPH ) has had strong clinical results. CBD oil is legal is all 50 states of the United States. And on top of this, the agricultural hemp it is derived from is also legal. However, on Dec. 14th, the DEA established a drug code to regulate CBD under the justification that it contained trace amounts of psychoactive THC – and THC is illegal. On top of this, CBD is on its way to becoming an Active Pharmaceutical Ingredient ‘API’ – assuming CBD drugs like Epidolex earn FDA approval.

To read more visit https://seekingalpha.com/article/4058204-medical-marijuana-inc-risky-avoid-now

Share This Post

Recent Articles

Leave a Reply

© 2019 Medical Marijuana Stocks. All rights reserved. Site Admin · Entries RSS · Comments RSS
Powered by WordPress · Designed by Theme Junkie
Subscribe now!
Get the latest content first.
©Medical Marijuana Stocks.info